Evidence map›Paper›PMID 33424265›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2020

Sex differences in pregabalin-seeking like behavior in a conditioned place preference paradigm.

Hashem O Alsaab, Ebtehal Altowairqi, Nada Alzahrani, Reem Alzahrani, Fahad S Alshehri, Atiah H Almalki, Walaa F Alsanie, Ahmed Gaber, Turki Alkhalifa, Ahmad Almalki and 2 more

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Blockade of Presynaptic αNeurochemical research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hashem O AlsaabAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Ebtehal AltowairqiDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Nada AlzahraniAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Reem AlzahraniAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Fahad S AlshehriDepartment of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Atiah H AlmalkiAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Walaa F AlsanieAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Ahmed GaberAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.
Turki AlkhalifaGeneral Administration for Precursors and Laboratories, General Directorate of Narcotics Control, Ministry of Interior, Riyadh, Saudi Arabia.
Ahmad AlmalkiGeneral Administration for Precursors and Laboratories, General Directorate of Narcotics Control, Ministry of Interior, Riyadh, Saudi Arabia.
Zahoor A ShahDepartment of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.
Yusuf S AlthobaitiAddiction and Neuroscience Research Unit, Taif University, Health Science Campus, Al Haweiah, Taif 21974, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance abuse is a chronic, relapsing disorder characterized by compulsive drug use regardless of negative consequences. Incremental increases in pregabalin abuse have been observed in Saudi Arabia and throughout the world. In previous studies, the potential for pregabalin abuse with escalating doses of the drug (30, 60, 90, and 120 mg/kg) were investigated in male mice. Notably, researchers have argued that women may exhibit a greater tendency to consume drugs without a prescription to alleviate stress and depression. Moreover, female subjects are more prone to impulsivity in drug intake or abuse than their male counterparts. Therefore, in the present study, we compared the potential for pregabalin abuse between male and female mice using a conditioned place preference paradigm. Male and female BALB/c mice were divided into four groups based on the pregabalin dose administered (30, 60, 90, or 120 mg/kg, intraperitoneal). Preference scores were then calculated and compared between male and female mice in each dosage group. Interestingly, preference scores were significantly higher in female mice than in male mice at dosages of 30 and 120 mg/kg. These findings indicate that female mice may be more prone to pregabalin abuse and tolerance than male mice. These results might be helpful to the healthcare providers and policymakers to consider these sex differences in choosing therapeutic plans and consider alternatives to the misused prescription medications.

Indexed as

AddictionConditioned place preferenceCPP, conditioned place preferenceDrug abuseER, estradiol receptorGABA, gamma-aminobutyric acidmGluR, metabotropic glutamate receptorPregabalinSex differences

Identifiers

PMID33424265
PMCPMC7783229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.